Details
| Stereochemistry | ACHIRAL |
| Molecular Formula | C13H30O6P2 |
| Molecular Weight | 344.3212 |
| Optical Activity | NONE |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
CC(C)OP(=O)(CP(=O)(OC(C)C)OC(C)C)OC(C)C
InChI
InChIKey=ODTQUKVFOLFLIQ-UHFFFAOYSA-N
InChI=1S/C13H30O6P2/c1-10(2)16-20(14,17-11(3)4)9-21(15,18-12(5)6)19-13(7)8/h10-13H,9H2,1-8H3
Tetraisopropyl methylenediphosphonate used in the synthesis of unsaturated phosphonocholines with enantioselective effects on neuronal tumor cell proliferation and viability. Also is used in the preparation of E2-bisphosphonate conjugates as potential anti-osteoporosis agents and in the preparation of AZT 5’-Triphosphate compounds, which display inhibitory effects on HIV-1 reverse transcriptase.
Approval Year
PubMed
| Title | Date | PubMed |
|---|---|---|
| Phosphorus stabilized carbene complexes: bisphosphonate dianion synthesis, reactivity and DFT studies of O~C~O zirconium(IV) complexes. | 2010-01-14 |
|
| Synthesis of AZT 5'-triphosphate mimics and their inhibitory effects on HIV-1 reverse transcriptase. | 2004-12-30 |
|
| Synthesis and use of novel ether phospholipid enantiomers to probe the molecular basis of the antitumor Effects of alkyllysophospholipids: correlation of differential activation of c-Jun NH(2)-terminal protein kinase with antiproliferative effects in neuronal tumor cells. | 2004-05-06 |
|
| Prostaglandin E2-bisphosphonate conjugates: potential agents for treatment of osteoporosis. | 1999-05 |
|
| Some phosphonic acid analogs as inhibitors of pyrophosphate-dependent phosphofructokinase, a novel target in Toxoplasma gondii. | 1995-01-06 |
| Name | Type | Language | ||
|---|---|---|---|---|
|
Preferred Name | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English |
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
216-765-0
Created by
admin on Mon Mar 31 22:20:24 GMT 2025 , Edited by admin on Mon Mar 31 22:20:24 GMT 2025
|
PRIMARY | |||
|
226577
Created by
admin on Mon Mar 31 22:20:24 GMT 2025 , Edited by admin on Mon Mar 31 22:20:24 GMT 2025
|
PRIMARY | |||
|
K46Y5V9U61
Created by
admin on Mon Mar 31 22:20:24 GMT 2025 , Edited by admin on Mon Mar 31 22:20:24 GMT 2025
|
PRIMARY | |||
|
DTXSID7044847
Created by
admin on Mon Mar 31 22:20:24 GMT 2025 , Edited by admin on Mon Mar 31 22:20:24 GMT 2025
|
PRIMARY | |||
|
1660-95-3
Created by
admin on Mon Mar 31 22:20:24 GMT 2025 , Edited by admin on Mon Mar 31 22:20:24 GMT 2025
|
PRIMARY | |||
|
74266
Created by
admin on Mon Mar 31 22:20:24 GMT 2025 , Edited by admin on Mon Mar 31 22:20:24 GMT 2025
|
PRIMARY |
SUBSTANCE RECORD